Որոնման արդյունքները - Bridget A. Robinson
- Ցուցադրվում են 1 - 20 արդյունքները 24
- Գնացեք Հաջորդ էջ
-
1
Nonhuman Primate Models of Human Immunology Ilhem Messaoudi, Ryan D. Estep, Bridget A. Robinson, Scott W. Wong
Հրապարակվել է 2010Revisão -
2
-
3
Cisplatin/carboplatin cross-resistance in ovarian cancer ME Gore, I Fryatt, E. Wiltshaw, Timothy Dawson, Bridget A. Robinson, A H Calvert
Հրապարակվել է 1989Artigo -
4
Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer Ekaterina Volkova, Jinny Willis, J. Elisabeth Wells, Bridget A. Robinson, Gabi U. Dachs, Margaret J. Currie
Հրապարակվել է 2010Artigo -
5
Mutations of Conserved Residues in the Major Homology Region Arrest Assembling HIV-1 Gag as a Membrane-Targeted Intermediate Containing Genomic RNA and Cellular Proteins Motoko Tanaka, Bridget A. Robinson, Kasana Chutiraka, Clair D. Geary, Jonathan C. Reed, Jaisri R. Lingappa
Հրապարակվել է 2015Artigo -
6
Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels Elizabeth J. Campbell, Gabi U. Dachs, Helen Morrin, Valerie Davey, Bridget A. Robinson, Margreet C.M. Vissers
Հրապարակվել է 2019Artigo -
7
Restoring physiological levels of ascorbate slows tumor growth and moderates HIF‐1 pathway activity in Gulo<sup>−/−</sup> mice Elizabeth J. Campbell, Margreet C.M. Vissers, Stephanie M. Bozonet, Arron Dyer, Bridget A. Robinson, Gabi U. Dachs
Հրապարակվել է 2014Artigo -
8
-
9
The angiogenic switch for vascular endothelial growth factor (VEGF)‐A, VEGF‐B, VEGF‐C, and VEGF‐D in the adenoma–carcinoma sequence during colorectal cancer progression Vickie Hanrahan, Margaret J. Currie, Sarah Gunningham, Helen Morrin, Prudence A. E. Scott, Bridget A. Robinson, Stephen B. Fox
Հրապարակվել է 2003Artigo -
10
First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients K. A. Mackenzie, J. Elisabeth Wells, K L Lynn, Jeremy Simcock, Bridget A. Robinson, Justin Roake, Margaret J. Currie
Հրապարակվել է 2009Artigo -
11
Increased Tumor Ascorbate is Associated with Extended Disease-Free Survival and Decreased Hypoxia-Inducible Factor-1 Activation in Human Colorectal Cancer Caroline Kuiper, Gabi U. Dachs, Delwyn Munn, Margaret J. Currie, Bridget A. Robinson, John F. Pearson, Margreet C.M. Vissers
Հրապարակվել է 2014Artigo -
12
-
13
-
14
-
15
Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells Barry D. Hock, K. A. Mackenzie, Nicholas B. Cross, K. G. Taylor, Margaret J. Currie, Bridget A. Robinson, Jeremy Simcock, Judith L. McKenzie
Հրապարակվել է 2011Artigo -
16
Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised co... Timothy Price, Diana Zannino, Kate Wilson, R. J. Simes, J Cassidy, Guy A. Van Hazel, Bridget A. Robinson, A. Broad, Vinod Ganju, Stephen P. Ackland, Niall C. Tebbutt
Հրապարակվել է 2011Artigo -
17
Deletion of the Monkeypox Virus Inhibitor of Complement Enzymes Locus Impacts the Adaptive Immune Response to Monkeypox Virus in a Nonhuman Primate Model of Infection Ryan D. Estep, Ilhem Messaoudi, Megan A. O’Connor, Helen Li, Jerald Sprague, Alex Barron, Flora Engelmann, Bonnie Yen, Michael F. Powers, John M. Jones, Bridget A. Robinson, Beata Orzechowska, Minsha Manoharan, Alfred W. Legasse, Shannon Planer, Jennifer Wilk, Michael K. Axthelm, Scott W. Wong
Հրապարակվել է 2011Artigo -
18
Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX... Niall C. Tebbutt, Kate Wilson, Val Gebski, Michelle M. Cummins, Diana Zannino, Guy A. Van Hazel, Bridget A. Robinson, A. Broad, Vinod Ganju, Stephen P. Ackland, Garry Forgeson, David Cunningham, Mark Saunders, Martin R. Stockler, Yujo Chua, John Zalcberg, R. J. Simes, Timothy Price
Հրապարակվել է 2010Artigo -
19
Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study Juan W. Valle, Daniel H. Palmer, Richard Jackson, Trevor F. Cox, John P. Neoptolemos, Paula Ghaneh, Charlotte Rawcliffe, Claudio Bassi, Deborah Stocken, David Cunningham, Derek O’Reilly, David Goldstein, Bridget A. Robinson, Christos S. Karapetis, Andrew Scarfe, F Lacaine, Juhani Sand, Jakob R. Izbicki, Julia Mayerle, Christos Dervenis, Attila Oláh, Giovanni Butturini, Pehr Lind, Mark R. Middleton, Alan Anthoney, Kate Sumpter, Ross Carter, Markus W. Büchler
Հրապարակվել է 2014Artigo -
20
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy... Guy A. Van Hazel, Volker Heinemann, Navesh Sharma, Michael Findlay, Jens Ricke, Marc Peeters, D Díaz Pérez, Bridget A. Robinson, Andrew Strickland, Tom Ferguson, Javier Rodríguez, H. Kröning, Ido Wolf, Vinod Ganju, Euan Walpole, Éveline Boucher, Thomas Tichler, Einat Shacham‐Shmueli, Alex Powell, Paul Eliadis, Richard Isaacs, David Price, Fred M Moeslein, Julien Taı̈eb, G. Bower, Val Gebski, Mark Van Buskirk, David Cade, Kenneth G. Thurston, Peter Gibbs
Հրապարակվել է 2016Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Internal medicine
Medicine
Cancer
Biology
Oncology
Chemotherapy
Gene
Colorectal cancer
Genetics
Biochemistry
Cancer research
Confidence interval
Gastroenterology
Hazard ratio
Immunology
Surgery
Virology
Virus
Pathology
Bevacizumab
Cell biology
Chemistry
Endocrinology
Environmental health
Immune system
Metastasis
Population
Progression-free survival
Angiogenesis
Ascorbic acid